2025.12.04
Special Interview with Dr. Lieve Ongena of VIB (Flanders Institute for Biotechnology)

This Newsletter features a special interview with Dr. Lieve Ongena, Senior Science Policy Manager and Head of the International Grants Office at VIB (Flanders Institute for Biotechnology) in Belgium, who also serves as a member of the Toyama Pharmaceutical Consortium Advisory Board.
Uncover the secrets behind Belgium’s transformation into a major life sciences hub through this exclusive discussion. This article details VIB’s successful model, showcasing how dedicated long-term funding for biotechnology research drives remarkable economic growth and innovation. The insights here are highly relevant for the Toyama Pharmaceutical Valley Development Consortium’s mission of regional revitalization.

  • This Newsletter is a revised version of articles originally published in “KTT Tsushin,” our email newsletter, on October 7 and October 15, 2025.
  • Reference: VIB (Flanders Institute for Biotechnology) https://vib.be